ALDH1 as a prognostic marker for lymph node metastasis in OSCC

Götz,Carolin; Bissinger,Oliver; Nobis,Christopher; Wolff,Klaus  Dietrich; Drecoll,Enken; Kolk,Andreas

doi:10.3892/br.2018.1131

ALDH1 as a prognostic marker for lymph node metastasis in OSCC

Authors:
- Carolin Götz
- Oliver Bissinger
- Christopher Nobis
- Klaus Dietrich Wolff
- Enken Drecoll
- Andreas Kolk
View Affiliations

Affiliations: Department of Oral and Maxillofacial Surgery, Technical University of Munich, D‑81675 Munich, Germany, Institute of Pathology, Klinikum Rechts der Isar, Technical University of Munich, D‑81675 Munich, Germany
Published online on: July 17, 2018 https://doi.org/10.3892/br.2018.1131
Pages: 284-290
Copyright: © Götz et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Long‑term survival in cases of head and neck squamous cell carcinoma, particularly oral squamous cell carcinoma (OSCC), remains a rare achievement in the field of clinical oncology. In recent years, the theory of cancer stem cells (CSCs) has emerged and been used to offer explanations for tumour recurrence and metastasis. The present aim was to investigate the role of aldehyde dehydrogenase 1 (ALDH1) as a CSC‑marker for OSCC and to determine the role of p16ink4a, which is also a surrogate marker of human papilloma virus (HPV), in the expression of ALDH1. The study cohort comprised of 186 surgically‑treated cases of OSCC. The primaries were located in the oral cavity. The expression of the CSC marker (CSCM) ALDH1 was evaluated via immunohistochemistry (IHC) of a tissue microarray. HPV detection was performed by polymerase chain reaction and an HPV Array kit. Furthermore, the IHC expression of p16ink4a was also analysed. Risk regression models as the Kruskal Wallis test was used to assess the association of CSCM and p16ink4a expression with tumour size and lymph node metastasis, and cox proportional hazards were analysed. Additionally, coexpression of the markers ALDH1 and p16ink4a was analysed with regard to associations with tumour classification. Overall, high expression of ALDH1 in lymph nodes was significantly associated with Union for International Cancer Control (UICC) stage IV (P=0.044) and T4 stage cancer (P=0.03). p16ink4a positivity, in cases of HPV negativity, was associated with worse survival rate compared with that of the total cohort (P=0.048). Collectively the data indicate that ALDH1 expression may be suitable for detection of unfavourable prognosis in OSCC patients, based in part on its apparent role as a marker of metastasis. HPV status was not statistically predictive of patient outcome or CSCM expression; however, p16ink4a remains a potential marker in HNSCC Further in vitro studies with ALDH1 and p16ink4a should be performed to evaluate the expression of ALDH1 and HPV in cell culture and to clarify the role of ALDH1 as a marker for increased invasiveness of OSCC cells.

View Figures

View References

1	La Torre G, Kirch W, Bes-Rastrollo M, Ramos RM, Czaplicki M, Gualano MR, Thümmler K, Ricciardi W and Boccia A; GHPSS, ; Collaborative Group, : Tobacco use among medical students in Europe: Results of a multicentre study using the Global Health Professions Student Survey. Public Health. 126:159–164. 2012. View Article : Google Scholar : PubMed/NCBI
2	Arantes LM, de Carvalho AC, Melendez ME, Carvalho AL and Goloni-Bertollo EM: Methylation as a biomarker for head and neck cancer. Oral Oncol. 50:587–592. 2014. View Article : Google Scholar : PubMed/NCBI
3	Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, et al: EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 26:3128–3137. 2008. View Article : Google Scholar : PubMed/NCBI
4	Kolk A, Wermker K, Bier H, Götz C and Eckert AW: Current surgical and adjuvant therapy concepts of malignant tumors of the facial skin and the pinna. Laryngorhinootologie. 94:77–85. 2015.(In German). PubMed/NCBI
5	Fakhry C, Sugar E, D'Souza G and Gillison M: Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort. PLoS One. 5:e119182010. View Article : Google Scholar : PubMed/NCBI
6	Bagan JV and Scully C: Recent advances in Oral Oncology 2007: Epidemiology, aetiopathogenesis, diagnosis and prognostication. Oral Oncol. 44:103–108. 2008. View Article : Google Scholar : PubMed/NCBI
7	Lindenblatt RC, Martinez GL, Silva LE, Faria PS, Camisasca DR and Lourenço SQ: Oral squamous cell carcinoma grading systems - analysis of the best survival predictor. J Oral Pathol Med. 41:34–39. 2012. View Article : Google Scholar : PubMed/NCBI
8	Mücke T, Koschinski J, Wolff KD, Kanatas A, Mitchell DA, Loeffelbein DJ, Deppe H and Rau A: Quality of life after different oncologic interventions in head and neck cancer patients. J Craniomaxillofac Surg. 43:1895–1898. 2015. View Article : Google Scholar : PubMed/NCBI
9	González-García R, Naval-Gías L, Román-Romero L, Sastre-Pérez J and Rodríguez-Campo FJ: Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: A retrospective analytic study of 500 patients. Head Neck. 31:1168–1180. 2009. View Article : Google Scholar : PubMed/NCBI
10	Park MJ, Roh JL, Kim SB, Choi SH, Nam SY and Kim SY: Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma. Eur J Cancer. 92:69–76. 2018. View Article : Google Scholar : PubMed/NCBI
11	Thomas SM, Bhola NE, Zhang Q, Contrucci SC, Wentzel AL, Freilino ML, Gooding WE, Siegfried JM, Chan DC and Grandis JR: Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Cancer Res. 66:11831–11839. 2006. View Article : Google Scholar : PubMed/NCBI
12	Kalyankrishna S and Grandis JR: Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol. 24:2666–2672. 2006. View Article : Google Scholar : PubMed/NCBI
13	Fouad YA and Aanei C: Revisiting the hallmarks of cancer. Am J Cancer Res. 7:1016–1036. 2017.PubMed/NCBI
14	Magee JA, Piskounova E and Morrison SJ: Cancer stem cells: Impact, heterogeneity, and uncertainty. Cancer Cell. 21:283–296. 2012. View Article : Google Scholar : PubMed/NCBI
15	Singh A and Settleman J: EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
16	Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
17	Nguyen LV, Vanner R, Dirks P and Eaves CJ: Cancer stem cells: An evolving concept. Nat Rev Cancer. 12:133–143. 2012. View Article : Google Scholar : PubMed/NCBI
18	Knudsen ES, Dervishaj O, Kleer CG, Pajak T, Schwartz GF and Witkiewicz AK: EZH2 and ALDH1 expression in ductal carcinoma in situ: Complex association with recurrence and progression to invasive breast cancer. Cell Cycle. 12:2042–2050. 2013. View Article : Google Scholar : PubMed/NCBI
19	Schäfer A, Teufel J, Ringel F, Bettstetter M, Hoepner I, Rasper M, Gempt J, Koeritzer J, Schmidt-Graf F, Meyer B, et al: Aldehyde dehydrogenase 1A1 - a new mediator of resistance to temozolomide in glioblastoma. Neuro-oncol. 14:1452–1464. 2012. View Article : Google Scholar : PubMed/NCBI
20	Reid P, Wilson P, Li Y, Marcu LG, Staudacher AH, Brown MP and Bezak E: In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status. PLoS One. 12:e01861862017. View Article : Google Scholar : PubMed/NCBI
21	Campos MS, Neiva KG, Meyers KA, Krishnamurthy S and Nör JE: Endothelial derived factors inhibit anoikis of head and neck cancer stem cells. Oral Oncol. 48:26–32. 2012. View Article : Google Scholar : PubMed/NCBI
22	Qian X, Wagner S, Ma C, Klussmann JP, Hummel M, Kaufmann AM and Albers AE: ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status. Oncol Rep. 29:1777–1784. 2013. View Article : Google Scholar : PubMed/NCBI
23	Sritippho T, Pongsiriwet S, Lertprasertsuke N, Buddhachat K, Sastraruji T and Iamaroon A: p16 - a Possible Surrogate Marker for High-Risk Human Papillomaviruses in Oral Cancer? Asian Pac J Cancer Prev. 17:4049–4057. 2016.PubMed/NCBI
24	Hoesli R, Birkeland AC, Rosko AJ, Issa M, Chow KL, Michmerhuizen NL, Mann JE, Chinn SB, Shuman AG, Prince ME, et al: Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma. Oral Oncol. 77:83–89. 2018. View Article : Google Scholar : PubMed/NCBI
25	Alipoor FJ, Asadi MH and Torkzadeh-Mahani M: MIAT lncRNA is overexpressed in breast cancer and its inhibition triggers senescence and G1 arrest in MCF7 cell line. J Cell Biochem. 18–Jan;2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
26	Zhao P, Hu YC and Talbot IC: Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma. World J Gastroenterol. 9:2202–2206. 2003. View Article : Google Scholar : PubMed/NCBI
27	Milanovic M, Fan DNY, Belenki D, Däbritz JHM, Zhao Z, Yu Y, Dörr JR, Dimitrova L, Lenze D, Monteiro Barbosa IA, et al: Senescence-associated reprogramming promotes cancer stemness. Nature. 553:96–100. 2018. View Article : Google Scholar : PubMed/NCBI
28	Okuma A, Hanyu A, Watanabe S and Hara E: p16^Ink4a and p21Cip1/Waf1 promote tumour growth by enhancing myeloid-derived suppressor cells chemotaxis. Nat Commun. 8:20502017. View Article : Google Scholar : PubMed/NCBI
29	Wolff KD, Follmann M and Nast A: The diagnosis and treatment of oral cavity cancer. Dtsch Arztebl Int. 109:829–835. 2012.PubMed/NCBI
30	Götz C, Drecoll E, Straub M, Bissinger O, Wolff KD and Kolk A: Impact of HPV infection on oral squamous cell carcinoma. Oncotarget. 7:76704–76712. 2016. View Article : Google Scholar : PubMed/NCBI
31	Bissinger O, Kolk A, Drecoll E, Straub M, Lutz C, Wolff KD and Götz C: EGFR and Cortactin: Markers for potential double target therapy in oral squamous cell carcinoma. Exp Ther Med. 14:4620–4626. 2017.PubMed/NCBI
32	Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 8:138–140. 1987.PubMed/NCBI
33	La Porta CA, Zapperi S and Sethna JP: Senescent cells in growing tumors: Population dynamics and cancer stem cells. PLOS Comput Biol. 8:e10023162012. View Article : Google Scholar : PubMed/NCBI
34	Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature. 414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
35	Solomon I, Voiculescu VM, Caruntu C, Lupu M, Popa A, Ilie MA, Albulescu R, Caruntu A, Tanase C, Constantin C, et al: Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember. Dis Markers. 2018:97878312018. View Article : Google Scholar : PubMed/NCBI
36	Burke HB: Outcome prediction and the future of the TNM staging system. J Natl Cancer Inst. 96:1408–1409. 2004. View Article : Google Scholar : PubMed/NCBI
37	Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
38	Magni M, Shammah S, Schiró R, Mellado W, Dalla-Favera R and Gianni AM: Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood. 87:1097–1103. 1996.PubMed/NCBI
39	Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
40	Boxberg M, Jesinghaus M, Dorfner C, Mogler C, Drecoll E, Warth A, Steiger K, Bollwein C, Meyer P, Wolff KD, et al: Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: Proposal for an adjusted grading system. Histopathology. 70:1125–1137. 2017. View Article : Google Scholar : PubMed/NCBI
41	Wu J, Mu Q, Thiviyanathan V, Annapragada A and Vigneswaran N: Cancer stem cells are enriched in Fanconi anemia head and neck squamous cell carcinomas. Int J Oncol. 45:2365–2372. 2014. View Article : Google Scholar : PubMed/NCBI
42	Ikawa M, Impraim CC, Wang G and Yoshida A: Isolation and characterization of aldehyde dehydrogenase isozymes from usual and atypical human livers. J Biol Chem. 258:6282–6287. 1983.PubMed/NCBI
43	Resetkova E, Reis-Filho JS, Jain RK, Mehta R, Thorat MA, Nakshatri H and Badve S: Prognostic impact of ALDH1 in breast cancer: A story of stem cells and tumor microenvironment. Breast Cancer Res Treat. 123:97–108. 2010. View Article : Google Scholar : PubMed/NCBI
44	Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS and Prince ME: Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck. 32:1195–1201. 2010. View Article : Google Scholar : PubMed/NCBI
45	Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
46	Xu J, Müller S, Nannapaneni S, Pan L, Wang Y, Peng X, Wang D, Tighiouart M, Chen Z, Saba NF, et al: Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer. Eur J Cancer. 48:1682–1691. 2012. View Article : Google Scholar : PubMed/NCBI
47	He KF, Zhang L, Huang CF, Ma SR, Wang YF, Wang WM, Zhao ZL, Liu B, Zhao YF, Zhang WF, et al: CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma. BioMed Res Int. 2014:8386322014. View Article : Google Scholar : PubMed/NCBI
48	Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, et al: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
49	Rasper M, Schäfer A, Piontek G, Teufel J, Brockhoff G, Ringel F, Heindl S, Zimmer C and Schlegel J: Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro-oncol. 12:1024–1033. 2010. View Article : Google Scholar : PubMed/NCBI
50	Bednarz-Knoll N, Nastały P, Żaczek A, Stoupiec MG, Riethdorf S, Wikman H, Müller V, Skokowski J, Szade J, Sejda A, et al: Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression. Oncotarget. 6:26789–26803. 2015. View Article : Google Scholar : PubMed/NCBI
51	Morimoto K, Kim SJ, Tanei T, Shimazu K, Tanji Y, Taguchi T, Tamaki Y, Terada N and Noguchi S: Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci. 100:1062–1068. 2009. View Article : Google Scholar : PubMed/NCBI
52	Alamgeer M, Ganju V, Kumar B, Fox J, Hart S, White M, Harris M, Stuckey J, Prodanovic Z, Schneider-Kolsky ME, et al: Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer. Breast Cancer Res. 16:R442014. View Article : Google Scholar : PubMed/NCBI
53	Sharpless NE: INK4a/ARF: A multifunctional tumor suppressor locus. Mutat Res. 576:22–38. 2005. View Article : Google Scholar : PubMed/NCBI
54	Emig R, Magener A, Ehemann V, Meyer A, Stilgenbauer F, Volkmann M, Wallwiener D and Sinn HP: Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation. Br J Cancer. 78:1661–1668. 1998. View Article : Google Scholar : PubMed/NCBI
55	Chen YW, Chu HC, Ze-Shiang Lin, Shiah WJ, Chou CP, Klimstra DS and Lewis BC: p16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cells. PLoS One. 8:e693892013. View Article : Google Scholar : PubMed/NCBI